Vijaya Bhatt is Professor, Section Leader of Malignant Hematology Section, Medical Director of Leukemia Program, Co-Leader of Cancer Prevention and Control Program. OpenAlex indexes 424 publications with 8,824 citations (h-index 42); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Updated 20 Oct 2026
Vijaya Bhatt, MD, is Professor, Section Leader of Malignant Hematology Section, Medical Director of Leukemia Program, Co-Leader of Cancer Prevention and Control Program at University of Nebraska Medical Center (UNMC). The public record shows 424 publications with 8,846 citations (h-index 42), centered on Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Retinoids in leukemia and cellular processes. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 13 companies, 1 NIH-funded awards (2023–2026).
- Most recent indexed publication: 2026 · American journal of hematology
- Top research focus: Acute Myeloid Leukemia Research
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 20 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 164.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Omaha, NE 68198-8102
Telephone
402-559-5600Registry record last updated 12 Mar 2015 · collected 28 Jul 2026.
Clinical trials
Updated 20 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Halt Aging in Survivors of Blood Cancers
Sponsor: University of Nebraska
- ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
Sponsor: University of Nebraska
- Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids
Sponsor: University of Nebraska
Industry payments
Updated 20 Oct 2026
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Syndax Pharmaceuticals, Inc.Program year20255 payments
- Geron CorporationProgram year20253 payments
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.5%Kinase inhibitor19.3%Jakafi61%Sprycel17%Tasigna12%Iclusig11%Part D<11 patientsBCL-2 Inhibitor7.3%Venclexta100%Part D≥11 patients+ 2 more classes in this area
Anti-infectives
24.6%Short-acting sulfonamides14.1%Sulfamethoxazole-Trimethoprim100%Part D≥19 patientsAzole Antifungal5.3%Posaconazole100%Part D<11 patients+ 2 more classes in this area
Dermatology
22.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor22.3%Acyclovir100%Part D≥26 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 20 Oct 2026
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Aging trajectories and outcomes of older adults with acute myeloid leukemia
University of Nebraska Medical Center
FY2026$515,428R37CA276928 - Aging trajectories and outcomes of older adults with acute myeloid leukemia
University of Nebraska Medical Center
FY2025$515,428R37CA276928 - Aging trajectories and outcomes of older adults with acute myeloid leukemia
University of Nebraska Medical Center
FY2024$489,655R37CA276928
Congress activity
Updated 20 Oct 2026
80 congress contributions (2013–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:
- Phase I trial of a novel first-in-class drug ONC201 as a post-transplant maintenance for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
ASH Annual Meeting
ASH2025Presenting author - Abstract 6471: Trends in chemotherapy utilization in acute myeloid leukemia (AML) in last 15 years
AACR Annual Meeting
AACR2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 20 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.
American journal of hematology
Clinical Trial2026 - Care of Older Adults with Acute Myeloid Leukemia: The Role of Geriatric Assessment.
Current treatment options in oncology
Review2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in OncologyArticle654 citations2017
- 03
- 04Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyArticle419 citations2019
- 05NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021Article320 citations2021
Network
Updated 20 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 20 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
healthtree.org/aml/community/directory/ne/buffett-nebraska/vijaya-bhatt
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthtree.org ↗ - Other
aamds.org/node/233
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Other
unmc.edu/intmed/divisions/onchem/faculty/bhatt.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 20 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- Board Certified in Internal Medicine
Hematology and Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancerletter.com ↗
- Member
Alliance Leukemia Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Member
NCCN Acute Myeloid Leukemia Guidelines Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Member
NCCN Hematopoietic Cell Transplantation Guidelines Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Member
Big Ten Cancer Research Consortium Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Secondary affiliations
appointments beyond the home institution- Co-Leader
Cancer Prevention and Control Program, Fred & Pamela Buffett Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”